Cross-border ads: CAP explains ASA's remit
CAP publishes an article explaining the ASA’s remit in relation to cross-border ads.
All Articles in Labelling and packaging
No hiding in the supply chain: CMA clarifies responsibility for green claims
The CMA provides clarification on supply chain responsibility when making environmental claims in new guidance supplementing the Green Claims Code and sector-specific guidance on making green claims about fashion products.
Zero tolerance: CAP reminds alcohol-free brands of their ad responsibilities
CAP publishes guidance note highlighting that ads marketing alcohol alternatives must display the ABV prominently
ICC publishes new edition of its Framework for Responsible Environmental Marketing Communications
The framework is a helpful tool for advertisers and supports self‑regulation of environmental claims.
Advertising and marketing in 2026: what businesses might expect in the UK and EU
This article explores key topics likely to shape 2026 regulatory agenda in the advertising and marketing industry in both the UK and the EU.
ASA trials AI monitoring of ads at scale in the alcohol industry
The ASA scales up its AI-based Active Ad Monitoring to review compliance in the alcohol industry.
Prove it or lose it: ASA and CAP clamp down on 'green disposal' claims
ASA research and rulings shed light on the use of claims like “recyclable”, “compostable” and “biodegradable”.
UK government’s view is that pure brand advertising is not in scope of the incoming advertising restrictions on less healthy foods
The minister for public health, Ashley Dalton MP, confirms the government’s view that pure brand advertising is not in scope of the incoming advertising restrictions on less healthy foods, Gregory Barton reports.
ASA’s active monitoring and strict approach to food supplement claims: five takeaways
Key takeaways for food manufacturers following a recent increase in ASA action against food supplement claims, Stefanie Lo reports.
Tonic health told to dump their denigrating comparative advertising
Painful reminder: medicinal claims are not permitted for unlicenced medicines treating menopause symptoms
ASA Active Ad Monitoring system successfully identifies non-compliant ad featuring medicinal claims for an unlicenced medicine. Stefanie Lo reports.
English High Court considers when ads are comparative by implication
English High Court considers when ads could be considered comparative in nature, composition, efficacy and/or quality by implication. Anna Matsiienko and Louisa Morrison report.
